Roth Capital Initiates Coverage On MediciNova with Buy Rating, Announces Price Target of $6
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Roth Capital analyst Boobalan Pachaiyappan initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $6.
Roth Capital analyst Boobalan Pachaiyappan initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $6.